Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.64 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.60 |
| ▸ | FAAH | O00519 | 2/20 | 0.58 |
| ▸ | RAD52 | P43351 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 6/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4883420 | 1.00 | NAAA (0.64) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL81047 | 1.00 | NAAA (0.64) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL8377208 | 1.00 | NAAA (0.64) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL8379909 | 1.00 | NAAA (0.64) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL5267200 | 1.00 | NAAA (0.64) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL6566958 | 0.98 | NAAA (0.62) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL394098 | 0.98 | NAAA (0.62) | NAAAEPHX1FAAHRAD52NPSR1 | |
| Hydrochloric Acid SCHEMBL5267197 | 0.98 | NAAA (0.62) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL27285973 | 0.98 | NAAA (0.62) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL168311 | 0.98 | NAAA (0.61) | NAAAEPHX1FAAHRAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240398825-A1 | MELOXICAM COMPOSITION, PHARMACEUTICAL PREPARATION, AND PREPARATION METHOD AND USE THEREOF | NANJING DELOVA BIOTECH CO., LTD. (CN) | 2024-12-05 | — | — | US | claimed |
| CN-117980327-A | Specific coupling of antibodies | 杭州多禧生物科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-114806527-A | Nonylphenol polyoxyethylene ether sodium oxalate ternary viscous micelle dirt degrading agent | 大庆瑞雪石油科技开发有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114040781-A | Formulation of conjugate of TUBULYSIN derivative and cell binding molecule | 杭州多禧生物科技有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-114040779-A | Conjugates of cell binding molecules containing branched linkers and cytotoxic agents | 杭州多禧生物科技有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-113423430-A | Amanitoxin conjugates containing branched linkers | 杭州多禧生物科技有限公司 | 2021-09-21 | — | — | CN | claimed |
| CN-113195487-A | 2, 3-diaminosuccinyl conjugate linkers | 杭州多禧生物科技有限公司 | 2021-07-30 | — | — | CN | claimed |
| CN-112272669-A | Cross-linked pyrrolobenzodiazepine dimer (PBD) derivatives and conjugates thereof | 杭州多禧生物科技有限公司 | 2021-01-26 | — | — | CN | claimed |
| CN-111093707-A | Tubulysin homolog conjugates containing branched linkers | 杭州多禧生物科技有限公司 | 2020-05-01 | — | — | CN | claimed |
| CN-109575645-A | A kind of aluminum paste and preparation method thereof for alcohol water type ink | 长沙族兴新材料股份有限公司 | 2019-04-05 | — | — | CN | claimed |
| CN-106726670-A | A kind of skin protection cosmetics comprising N acyl aminos hydrochlorate/plant peptide combinations and preparation method thereof | 长沙普济生物科技股份有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106491380-A | Special N acylamino acids anion surfactant type mildy wash/cream of a kind of face cleaning instrument and preparation method thereof | 长沙普济生物科技股份有限公司 | 2017-03-15 | — | — | CN | claimed |
| EP-4736873-A1 | ANTI-IL-4RALPHA ANTIBODY FORMULATION, PREPARATION METHOD THEREFOR, AND USE THEREOF | Bio-Thera Solutions, Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| US-20250257116-A1 | ANTI-CLEAVAGE MUTANT OF CD16 FOR ENHANCING CELL FUNCTION | NEUKIO BIOTHERAPEUTICS (SHANGHAI) CO., LTD. (CN) | 2025-08-14 | — | — | US | disclosed |
| CN-114728092-B | Edge block with improved odor performance | 西姆莱斯股份公司 | 2025-02-28 | — | — | CN | disclosed |
| EP-4509524-A1 | ANTI-SPLICING MUTANT OF CD16 FOR ENHANCING CELL FUNCTION | Neukio Biotherapeutics (Shangai ) Co., Ltd. (CN) | 2025-02-19 | — | — | EP | disclosed |
| WO-1985000614-A1 | PROCESS FOR PREPARING PIGMENT COMPOSITIONS | SILBERLINE LIMITED (GB) | 1985-02-14 | — | — | WO | disclosed |
| US-4386001-A | Marine crankcase lubricant | TEXACO INC. (US) | 1983-05-31 | — | — | US | disclosed |
| US-4375418-A | CALCIUM SULFONATE, CALCIUM PHENOLATE, ZINC DIHYDROCARBYLDITHIOPHOSPHATE, POLYALKENESUCCINIMIDE, ACYL GLYCINE OXAZOLINE | TEXACO INC. (US) | 1983-03-01 | — | — | US | disclosed |
| US-4375417-A | ACYL GLYCINE OXAZOLINE | TEXACO INC. (US) | 1983-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240398825-A1 | MELOXICAM COMPOSITION, PHARMACEUTICAL PREPARATION, AND PREPARATION METHOD AND USE THEREOF | MB, PTGES, OPRM1 | NAAA 1993/4885EPHX1 1132/4885FAAH 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.